MARKET

VNDA

VNDA

Vanda Pharma
NASDAQ
7.57
+0.34
+4.70%
Closed 19:19 02/06 EST
OPEN
7.37
PREV CLOSE
7.23
HIGH
7.72
LOW
7.30
VOLUME
1.09M
TURNOVER
--
52 WEEK HIGH
9.60
52 WEEK LOW
3.809
MARKET CAP
447.36M
P/E (TTM)
-5.2882
1D
5D
1M
3M
1Y
5Y
1D
Vanda Pharmaceuticals Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results
Reuters · 4d ago
Weekly Report: what happened at VNDA last week (0126-0130)?
Weekly Report · 02/02 09:14
Biotech Stocks Facing FDA Decision In February 2026
NASDAQ · 01/28 03:44
Weekly Report: what happened at VNDA last week (0119-0123)?
Weekly Report · 01/26 09:14
Vanda Pharmaceuticals Advances Ponesimod Into Phase 3 Psoriasis Study: What Investors Should Know
TipRanks · 01/23 16:31
Weekly Report: what happened at VNDA last week (0112-0116)?
Weekly Report · 01/19 09:15
Weekly Report: what happened at VNDA last week (0105-0109)?
Weekly Report · 01/12 09:15
BUZZ-U.S. STOCKS ON THE MOVE-Bloom Energy, Tyson Foods, Voyager Technologies
Reuters · 01/08 15:44
More
About VNDA
Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of therapies to address unmet medical needs and improve the lives of patients. The Company’s commercial portfolio consist of three products: Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and for the treatment of nighttime sleep disturbances in Smith-Magenis syndrome (SMS) and PONVORY for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. In addition, it has a number of drugs and/or additional indications for current products in development, including Bysanti, Tradipitant, Imsidolimab, VTR-297, VQW-765, and others. Bysanti is the active metabolite of Fanapt.

Webull offers Vanda Pharmaceuticals Inc. stock information, including NASDAQ: VNDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VNDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VNDA stock methods without spending real money on the virtual paper trading platform.